Stock MOREPENLAB MOREPEN LABORATORIES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Morepen Laboratories Limited

Equities

MOREPENLAB

INE083A01026

Market Closed - Bombay S.E.
Other stock markets
 03:30:51 26/06/2024 pm IST 		5-day change 1st Jan Change
55.53 INR -2.34% Intraday chart for Morepen Laboratories Limited +2.21% +14.42%
21/05 Morepen Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
30/03 Morepen Laboratories Limited Announces Resignation of Lalit Kumar Baregama, Chief Growth Officer CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Morepen Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
CI
Morepen Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Morepen Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
CI
Morepen Laboratories to Transfer Formulation Distribution and Marketing Business to Subsidiary
MT
Morepen Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
CI
Morepen Laboratories' Net Profit Drops in Fiscal Q4
MT
Morepen Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
CI
US FDA Clears Morepen Laboratories' Baddi, India
MT
Morepen Laboratories Forms Wholly-Owned Subsidiary
MT
Morepen Laboratories Limited Announces Incorporation of Wholly Owned Subsidiary
CI
Morepen Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
CI
Morepen Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
CI
Morepen Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
CI
Morepen Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022
CI
Morepen Laboratories Sees Drop in Fiscal Q4 Consolidated Net Profit
MT
Morepen Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2022
CI
Morepen Laboratories Posts Decline in Fiscal Q3 Consolidated Net Profit
MT
Morepen Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021
CI
Morepen Gets USFDA Approval for Fexofinadine
CI
Morepen Laboratories Clocks 38% Jump in Fiscal Q2 Consolidated Profit
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MOREPENLAB Stock
  4. News Morepen Laboratories Limited
  5. Highlights